We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.64B
AUM Growth
+$176M
Cap. Flow
+$130M
Cap. Flow %
7.88%
Top 10 Hldgs %
4.45%
Holding
2,011
New
451
Increased
540
Reduced
511
Closed
490

Top Buys

Rank Stock Value
1
BG icon
Bunge Global
BG
+$9.2M
2
YUMC icon
Yum China
YUMC
+$7.54M
3
GILD icon
Gilead Sciences
GILD
+$7.27M
4
PPL
PPL Corp
PPL
+$6.17M
5
BABA icon
Alibaba
BABA
+$5.79M

Top Sells

Rank Stock Value
1
HLT icon
Hilton Worldwide
HLT
+$10.5M
2
NBIS
Nebius Group N.V.
NBIS
+$8.88M
3
TSLA icon
Tesla
TSLA
+$6.99M
4
BKNG icon
Booking.com
BKNG
+$6.63M
5
VEON icon
VEON
VEON
+$5.47M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.45%
2 Industrials 13.59%
3 Technology 12.59%
4 Healthcare 12.43%
5 Financials 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCN icon
951
FTI Consulting
FCN
$4.4B
$487K 0.03%
+11,345
New +$463K
ZYNE
952
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$486K 0.03%
+38,800
New +$445K
CBPX
953
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$486K 0.03%
17,268
-39,061
-69% -$1.06M
AMKR icon
954
Amkor Technology
AMKR
$12.4B
$485K 0.03%
48,285
+37,626
+353% +$403K
ASRT
955
DELISTED
Assertio
ASRT
$483K 0.03%
999
-1,639
-62% -$637K
CADE
956
DELISTED
Cadence Bancorporation
CADE
$482K 0.03%
17,766
+1,980
+13% +$47.7K
BBBY
957
DELISTED
Bed Bath & Beyond Inc
BBBY
$480K 0.03%
21,829
+8,342
+62% +$181K
HAFC icon
958
Hanmi Financial
HAFC
$945M
$479K 0.03%
+15,773
New +$486K
NTUS
959
DELISTED
Natus Medical Inc
NTUS
$478K 0.03%
12,526
-531
-4% -$21.2K
NRT
960
North European Oil Royalty Trust
NRT
$87.4M
$476K 0.03%
68,335
– –
SAIA icon
961
Saia
SAIA
$9.27B
$475K 0.03%
6,714
+1,847
+38% +$118K
VVV icon
962
Valvoline
VVV
$4.9B
$475K 0.03%
18,952
-5,769
-23% -$139K
R icon
963
Ryder
R
$9.83B
$474K 0.03%
5,630
-9,899
-64% -$809K
CVS icon
964
CVS Health
CVS
$133B
$473K 0.03%
+6,526
New +$474K
PLYA
965
DELISTED
Playa Hotels & Resorts
PLYA
$473K 0.03%
43,808
+12,845
+41% +$137K
MDSO
966
DELISTED
Medidata Solutions, Inc.
MDSO
$473K 0.03%
+7,457
New +$531K
CRBP icon
967
Corbus Pharmaceuticals
CRBP
$166M
$472K 0.03%
2,217
-1,143
-34% -$245K
PAGP icon
968
Plains GP Holdings
PAGP
$5.21B
$472K 0.03%
21,513
-16,230
-43% -$342K
ARNA
969
DELISTED
Arena Pharmaceuticals Inc
ARNA
$472K 0.03%
13,880
-13,704
-50% -$390K
CTBI icon
970
Community Trust Bancorp
CTBI
$1.42B
$471K 0.03%
10,009
-10,353
-51% -$499K
CDR
971
DELISTED
Cedar Realty Trust, Inc
CDR
$469K 0.03%
11,677
-7,060
-38% -$274K
VMI icon
972
Valmont Industries
VMI
$9.3B
$468K 0.03%
+2,819
New +$459K
CTAS icon
973
Cintas
CTAS
$81.9B
$466K 0.03%
11,960
-7,768
-39% -$295K
EBSB
974
DELISTED
Meridian Bancorp, Inc.
EBSB
$463K 0.03%
22,497
-48,553
-68% -$960K
PBI icon
975
Pitney Bowes
PBI
$2.4B
$461K 0.03%
+41,216
New +$486K
37 38
39
40 41

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GSA Capital Partners held 2,011 positions worth $1.64B, up 12% from $1.47B the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

GSA Capital Partners deployed $130M of net new capital in Q4 2017, opening 451 new positions and adding to 540 existing holdings. Its largest new stake was PPL Corp: 171,648 shares worth $5.31M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Nebius Group N.V., an estimated $8.88M trimmed.

  • GSA Capital Partners's largest Q4 2017 buy was PPL Corp: 171,648 shares worth $5.31M.
  • GSA Capital Partners added most to Bunge Global in Q4 2017, an estimated $9.2M increase.
  • GSA Capital Partners's biggest Q4 2017 reduction was Nebius Group N.V., cutting an estimated $8.88M.
  • GSA Capital Partners fully exited Hilton Worldwide in Q4 2017, selling an estimated $10.5M.
  • GSA Capital Partners's ten largest holdings make up 4.5% of its $1.64B portfolio in Q4 2017.
  • GSA Capital Partners opened 451 new positions and closed 490 in Q4 2017.
  • GSA Capital Partners's portfolio value rose 12% quarter-over-quarter to $1.64B.

Based on GSA Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.